1. Bruce GM., Pleus RC., Snyder SA. (2010) Toxicological relevance of pharmaceuticals in drinking water. Environ Sci Technol;44:5619–26. [DOI:10.1021/es1004895]

2. Caban M., Lis E., Kumirska J., Stepnowski P. (2015) Determination of pharmaceutical residues in drinking water in Poland using a new SPE-GC-MS (SIM) method based on Speedisk extraction disks and DIMETRIS derivatization. Science of The Total Environment, Volume 538, Pages 402-411. [DOI:10.1016/j.scitotenv.2015.08.076]

3. Farm M. S. & Belitz K. (2011) Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking-water supply in California. Science of the Total Environment, Volume 409, Issue 18, Pages 3409-3417. [DOI:10.1016/j.scitotenv.2011.05.053]

4. Gaffney V., Almeida C. M.M., Rodrigues A., Ferreira E., Benoliel M, Vale Cardoso V. (2015) Occurrence of pharmaceuticals in a water supply system and related human health risk assessment, Water Research, Volume 72, Pages 199-208. [DOI:10.1016/j.watres.2014.10.027]

5. Gabarrón S., Gernjak W., Valero V., Barceló A., Petrovic M., Rodríguez-Roda, I. (2017) Evaluation of emerging contaminants in a drinking water treatment facilities using electrodialysis reversal technology, Journal of Hazardous Materials, Volume 309, Pages 192-201. [DOI:10.1016/j.jhazmat.2016.02.015]

6. Klamerth N, Rizzo L, Malato S, Maldonado M.I., Agüera A., Fernández-Alba A.R. (2010) Degradation of fifteen emerging contaminants at μg L−1 initial concentrations by mild solar photo-Fenton in MWTP effluents, Water Research, Volume 44, Issue 2, Pages 545-554. [DOI:10.1016/j.watres.2009.09.059]

7. Lin T., Yu S., Chen W. (2016) Occurrence, removal and risk assessment of pharmaceutical and personal care products (PPCPs) in an advanced drinking water treatment facilities (ADWTP) around Taihu Lake in China Chemosphere, Volume 152, Pages 1-9.

8. Lokesh P. Padhye, Hong Yao, Francis T. Kung'u, Ching-Hua Huang (2014) Year-long evaluation on the occurrence and fate of pharmaceuticals, personal care products, and endocrine disrupting chemicals in an urban drinking water treatment facilities Water Research, Volume 51, Pages 266-276. [DOI:10.1016/j.watres.2013.10.070]

9. Luque-Espinar J.A., Navas N., Chica-Olmo M., Cantarero-Malagón S., Chica-Rivas L. (2015) Seasonal occurrence and distribution of a group of ECs in the water resources of Granada city metropolitan areas (South of Spain): Pollution of raw drinking water Journal of Hydrology, Volume 531, Part 3, Pages 612-625. [DOI:10.1016/j.jhydrol.2015.10.066]

10. Mompelat S., Le Bot B., Thomas O. (2009) Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environment International, Volume 35, Issue 5, Pages 803-814. [DOI:10.1016/j.envint.2008.10.008]

11. Phillips PJ, Smith SG, Kolpin DW, Zaugg SD, Buxton HT, Furlong ET (2010) Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ Sci Technol; 44:4910–6. [DOI:10.1021/es100356f]

12. Postigo C. & Richardson S (2014) Transformation of pharmaceuticals during oxidation/disinfection processes in drinking water treatment. Journal of Hazardous Materials, Volume 279, 30, Pages 461-475. [DOI:10.1016/j.jhazmat.2014.07.029]

13. Rosal R., Antonio Rodríguez A., Perdigón-Melón J., Petre A., García-Calvo E., José Gómez M., Agüera A., Amadeo R. Fernández-Alba A. R. (2010) Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation, Water Research, Volume 44, Issue 2, Pages 578-588. [DOI:10.1016/j.watres.2009.07.004]

14. Vergili I . (2013) Application of nanofiltration for the removal of carbamazepine, diclofenac and ibuprofen from drinking water sources Istanbul University, Journal of Environmental Management, Volume 127, Pages 177-187. [DOI:10.1016/j.jenvman.2013.04.036]